Printer Friendly

VITAL HEART SYSTEMS, INC. ANNOUNCES VERY SUCCESSFUL LAUNCH OF VITAL HEART CHECKPOINT CENTERS

 MINNEAPOLIS, June 24 /PRNewswire/ -- In the first 10 days, the company has received 7 contracts to share revenues with the partners of
Vital Heart CheckPoint(TM) centers. Vital Heart Systems, Inc. (NASDAQ:


VHRT) launched a new program called the Vital Heart CheckPoint on June 1, 1993 to place its SV 4000 variance cardiograph in upscale health fitness centers in conjunction with prominent, local cardiologists. Results of the test are referred to the cardiologist for review and interpretation. Initial responses in the test market in Southern California have been very favorable. Vital Heart Systems plans to roll out the program to three additional regions by September, 1993.
 "People are becoming more aware of the importance of preventive healthcare. There is an increasing demand for an inexpensive, non- invasive, accurate screening test for unknown heart disease," said Robert Tatum, president and chief executive officer at Vital Heart Systems' annual meeting of shareholders. "It is interesting to note that people are concerned enough about health, that they will pay out of their own pocket for the test without insurance reimbursement."
 Vital Heart Systems also announced today that it has received delivery of its first Digital Equipment Corporation (DEC) based variance cardiograph product, the SV 5000. The company has commenced acceptance testing for its new product. With the new DEC product, the time for a test has been cut in half. The new system, produced by DEC, has reduced manufacturing cost by more than 50 percent. The company's previously announced product introduction for the SV 5000 remains on schedule.
 Vital Heart Systems, Inc., with headquarters in Beverly, Mass., develops and markets the Variance Cardiograph (TM), a non-invasive, stress-free, diagnostic instrument to aid physicians in the diagnosis of coronary artery disease. The stock of Vital Heart Systems Inc., is traded on the over-the-counter under the NASDAQ symbol VHRT.
 -0- 6/24/94
 /CONTACT: Deborah Meacock, director-investor relations of Vital Heart Systems, 612-341-4489/
 (VHRT)


CO: Vital Heart Systems, Inc. ST: Minnesota, Massachusetts IN: MTC SU:

DH-TS -- NY011 -- 5204 06/24/93 09:49 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 24, 1993
Words:338
Previous Article:NAUSEA REDUCED IN MIGRAINE PATIENTS FOLLOWING ADMINISTRATION OF DHE-45, STUDY SHOWS
Next Article:SYSTEMIX REPORTS HIV FINDING IN 'NATURE'
Topics:


Related Articles
VITAL HEART SYSTEMS ANNOUNCES A JOINT CARDIOGRAPH DEVELOPMENT PROJECT WITH DIGITAL EQUIPMENT CORPORATION
VITAL HEART SYSTEMS LAUNCHES EUROPEAN DISTRIBUTOR NETWORK
VITAL HEART SYSTEMS RECEIVES $1,962,093 IN PROCEEDS FROM WARRANT REDEMPTION
VITAL HEART SYSTEMS, INC. ANNOUNCES SALE OF FOUR VARIANCE CARDIOGRAPHS TO HOSPITAL CORPORATION OF AMERICA
VITAL HEART SYSTEMS ENTERS INTO EXCLUSIVE OPTION AGREEMENT TO PURCHASE NEW TECHNOLOGY
VITAL HEART SYSTEMS ANNOUNCES SALES TO NEW SCANDINAVIAN DISTRIBUTOR FOR THE FOURTH QUARTER 1992
VITAL HEART SYSTEMS' RECENTLY ELECTED PRESIDENT & CEO AND EXECUTIVE VICE PRESIDENT ARE ELECTED TO BOARD OF DIRECTORS
VITAL HEART SYSTEMS ANNOUNCES RAPID ACCEPTANCE OF ITS VITAL HEART CHECKPOINT CENTERS IN SOUTHERN CALIFORNIA
VITAL HEART SYSTEMS AND BETH ISRAEL HOSPITAL TO EVALUATE NEW INSTRUMENT FOR PATIENTS AT RISK FOR 'SUDDEN DEATH'
VITAL HEART SYSTEMS ANNOUNCES LICENSING AGREEMENT

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters